Karnataka's Food Safety and Drug Administration canceled a Bengaluru "Peptide Party" on August 29 and questioned its organizers, Upsurge Labs LLP, according to a report in The Indian Express on the country's fast-growing biohacking scene. Regulators asked about the ingredients in the products, the legality and safety of mixing them, and the truth behind claims of health benefits.
Peptides are short chains of the building blocks the body uses to carry out different tasks, and some are being sold or promoted as ways to encourage growth hormone release or repair damaged tissue. The report notes that many of those claims rest on early research, often in animals, rather than reliable studies in humans. Some of the compounds involved, it says, are bought online by makers posing as researchers.
Why the clinics are not regulated
The Express describes a grey market in which unapproved therapies are relabeled by premium aesthetic clinics as "elective wellness treatment" or "supplement cocktails," which sidesteps traditional drug approval. NAD+ infusions are the headline product, marketed as bypassing the gut to deliver the coenzyme straight into the bloodstream, though the report states scientists have yet to establish how much infused NAD+ reaches cells intact.
Dr Rashmi Sharma, a dermatologist at Fortis Vasant Kunj, describes "glow-up bars" offering pre-party vitamin and glutathione drips. The reporting is blunt about the payoff: there is little evidence that such injections reliably boost energy or improve youthful appearance.
A $7.53 billion forecast
Grand View Research estimated India's broad biohacking market at $1.21 billion in 2025, with a forecast of $7.53 billion by 2033. That growth lands alongside a demographic shift the report sets out plainly: people aged 60 and above are expected to make up 20.8 per cent of India's population by 2050, against 8.6 per cent in 2011.
Dr Prasun Chatterjee, president of the Indian Academy of Geriatrics, says peptide preparations raise questions about purity, impurities, dosing and how the body responds to substances not adequately studied for the intended use. His line is the sharpest in the piece: an ingredient's presence in the body does not establish that administering more of it will improve health.
Bottom line
A regulator asking an event organizer what is actually in the vials is the cheapest form of oversight available, and India now has one documented instance of it. What remains unsettled is whether any of these interventions do what the clinics selling them say.
Comments (0)
Discussion happens on Reddit.
Go to r/PeptideNewsroomQuestions and corrections go to r/PeptideNewsroom.